Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Change in Acquisitions & Divestments (2016 - 2025)

Lipocine (LPCN) has disclosed Change in Acquisitions & Divestments for 10 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 11.94% year-over-year to $5.9 million, compared with a TTM value of $25.1 million through Sep 2025, down 32.16%, and an annual FY2024 reading of $35.4 million, down 1.67% over the prior year.
  • Change in Acquisitions & Divestments was $5.9 million for Q3 2025 at Lipocine, up from $4.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $25.2 million in Q1 2022 and bottomed at $450000.0 in Q1 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $8.3 million, with a median of $6.7 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 89.66% in 2021, then surged 5506.33% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $1.4 million in 2021, then soared by 914.29% to $14.2 million in 2022, then decreased by 14.79% to $12.1 million in 2023, then fell by 13.22% to $10.5 million in 2024, then plummeted by 43.81% to $5.9 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for LPCN at $5.9 million in Q3 2025, $4.5 million in Q2 2025, and $4.2 million in Q1 2025.